Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Teerlink JR, et al. Among authors: anand i. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185990 Clinical Trial.
High Output Cardiac Failure.
Anand IS, Florea VG. Anand IS, et al. Curr Treat Options Cardiovasc Med. 2001 Apr;3(2):151-159. doi: 10.1007/s11936-001-0070-1. Curr Treat Options Cardiovasc Med. 2001. PMID: 11242561
Surrogate end points in heart failure.
Anand IS, Florea VG, Fisher L. Anand IS, et al. J Am Coll Cardiol. 2002 May 1;39(9):1414-21. doi: 10.1016/s0735-1097(02)01773-4. J Am Coll Cardiol. 2002. PMID: 11985901 Free article. Review.
Anemia and its relationship to clinical outcome in heart failure.
Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB. Anand I, et al. Circulation. 2004 Jul 13;110(2):149-54. doi: 10.1161/01.CIR.0000134279.79571.73. Epub 2004 Jun 21. Circulation. 2004. PMID: 15210591 Clinical Trial.
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.
Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, Ruschitzka F, Lüscher TF; EARTH investigators. Anand I, et al. Lancet. 2004 Jul 24-30;364(9431):347-54. doi: 10.1016/S0140-6736(04)16723-8. Lancet. 2004. PMID: 15276394 Clinical Trial.
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Lindenfeld J, et al. Among authors: anand i. Circulation. 2007 Jan 16;115(2):204-12. doi: 10.1161/CIRCULATIONAHA.106.629261. Epub 2006 Dec 26. Circulation. 2007. PMID: 17190867 Clinical Trial.
Predicting survival in heart failure.
Florea VG, Anand IS. Florea VG, et al. Curr Cardiol Rep. 2007 May;9(3):209-17. doi: 10.1007/BF02938352. Curr Cardiol Rep. 2007. PMID: 17470334 Review.
550 results